Abstract
Metastasis remains a critical - and largely elusive - target in the race to prevent cancer-related deaths. Such is true in nasopharyngeal carcinoma (NPC), where the presentation or development of metastatic disease is usually fatal. In this edition of Theranostics, Qi et al. demonstrate a critical role of the zinc-finger transcription factor, OVOL2, in suppressing metastasis and maintaining an epithelial phenotype. These data add to the depth of understanding of the metastatic program in NPC, and may eventually lead to a druggable target in late-stage NPC.
Cite
CITATION STYLE
Song, K. A., & Faber, A. C. (2018). OVOL2 in metastasis prevention in NPC. Theranostics. Ivyspring International Publisher. https://doi.org/10.7150/thno.25181
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.